Segmentectomy
Segmentectomy is a medical procedure with 10 clinical trials. Currently 5 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
1 of 1 finished
0.0%
0 ended early
5
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Segmentectomy After Induction Therapy (SAINT)
Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm
Postoperative Pulmonary Function Assessment Based on Deep Learning Study
SEgmentectomy Versus Lobectomy in T1C Non-Small Cell Lung Cancer (SELTIC)
Segmentectomy for Solid-dominant Lung Cancer
Clinical Trials (10)
Segmentectomy After Induction Therapy (SAINT)
Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm
Postoperative Pulmonary Function Assessment Based on Deep Learning Study
SEgmentectomy Versus Lobectomy in T1C Non-Small Cell Lung Cancer (SELTIC)
Segmentectomy for Solid-dominant Lung Cancer
Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)
Contribution of 3D Printing in Anatomical Lung Segmentectomies.
Comparison of Segmentectomy Versus Lobectomy for Non-small Cell Lung Cancer ≤ 2 cm in the Middle Third of the Lung Field
Comparison Between Wedge Resection and Segmentectomy for Ground Glass Opacity- Dominant Stage IA NSCLC
Comparison of Lobectomy and Segmentectomy for cT1aN0M0 Peripheral NSCLC
All 10 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 10